Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib Study
Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia